Myeloma and Plasma Cell Disorders Meeting 2019
30 October 2019, 2:00 pm–6:00 pm
![UCL Myeloma and Plasma Cell Disorders Meeting 2019](https://www.ucl.ac.uk/cancer/sites/cancer/files/styles/large_image/public/events/myeloma_meeting_2019_web.jpg?itok=J_tTXbal)
This annual scientific exchange meeting, organised by the UCLH Centre for Myeloma and Plasma Cell Disorders, provides an opportunity to hear, share and discuss advances in clinical and research activities. Free registration.
Event Information
Open to
- All
Availability
- Yes
Organiser
-
UCL Cancer Institute
Location
-
LT C3.09UCL Institute of Education20 Bedford WayLondonWC1H 0AL
Programme
14:00 Welcome - Dr Rakesh Popat (Lecture Theatre C3.09)
Understanding and harnessing immune function
- Chair: Prof Kwee Yong
14:05 Immunomodulatory targets on the clinical horizon - Dr Kyohei Nakamura, Smyth Lab
14:25 How do insights from animal models advance clinical care in myeloma? - Dr Kim De Veirman, Vanderkerken Lab
14:45 CAR T therapy in myeloma: an update - Dr Lydia Lee
Advances and uncertainties in clinical practice
- Chair: Dr Jonathan Sive
15:05 Smouldering myeloma: What should we be doing? - Prof Kwee Yong
15:25 COFFEE BREAK (Room C3.11)
Advances and uncertainties in clinical practice (cont.) Chair: Dr Jonathan Sive
15:50 Novel myeloma treatments and clinical trials at UCLH - Dr Rakesh Popat
16:10 NICE appraisals: How to integrate these into the treatment pathway? - Dr Neil Rabin
Plenary lecture
- Chair: Dr Ashu Wechalekar
16:30 Where do new immunotherapies fit into the myeloma treatment pathway? - Dr Shaji Kumar
Clinical case discussion
- Chair: Dr Neil Rabin
17:30 Presentation of clinical cases - Dr Jonathan Sive and Dr Chara Kyriakou
18:00 Summary and close - Prof Kwee Yong
18:15 onwards: Drinks reception
Parallel Session for Clinical Nurse Specialists and Trial Practitioners
14:05 - 15:05 - Coordinated and run by Aviva Cerner, UCH Myeloma CNS. (Room C3.13)
- Nurse-led clinics
- Best practice Daratumumab infusions
- Management of treatment toxicities
This meeting is approved for 3 CPD credits by the Royal College of Pathologists.